Molecular characterization of Staphylococcus Aureus and Influenza virus Coinfections in patients with fatal pneumonia

Journal of Clinical Microbiology

Volumn 51, Issue 12, 2013, Pages 4223-4225

  Denison, Amy M ^a   DeLeon Carnes, Marlene ^a   Blau, Dianna M ^a   Shattuck, Eric C ^a,c   McDougal, Linda K ^b   Rasheed, James K ^b   Limbago, Brandi M ^b   Zaki, Sherif R ^a   Paddock, Christopher D ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; FORMALDEHYDE; PANTON VALENTINE LEUKOCIDIN; PENICILLIN BINDING PROTEIN 2A;

2009 H1N1 INFLUENZA; ADULT; AGED; ARTICLE; BRONCHOPNEUMONIA; CONTROLLED STUDY; DISEASE DURATION; FATALITY; GENETIC MARKER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; INFLAMMATORY INFILTRATE; INFLUENZA A; INFLUENZA B; INFLUENZA VIRUS A; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; MECA GENE; MIXED INFECTION; MOLECULAR GENETICS; NONHUMAN; NUCLEIC ACID ANALYSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SPA TYPE T008 GENE; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL PROTEINS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; COINFECTION; EXOTOXINS; FEMALE; GENOTYPE; HUMANS; INFANT; INFLUENZA, HUMAN; LEUKOCIDINS; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; PNEUMONIA, STAPHYLOCOCCAL; STAPHYLOCOCCAL PROTEIN A; STAPHYLOCOCCUS AUREUS; YOUNG ADULT;

EID: 84889874112     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02503-13     Document Type: Article

References (31)

1. Haessler SD, Brown RB. 2009. Pneumonia caused by Staphyloccocus aureus. Curr. Resp. Med. Rev. 5:62-67.
2. Morens DM, Taubenberger JK, Fauci AS. 2008. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J. Infect. Dis. 198:962-970.
3. Oseasohn R, Adelson L, Kaji M. 1959. Clinicopathologic study of thirtythree fatal cases of Asian influenza. N. Engl. J. Med. 260:509-518.
4. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinivasan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, McDonald LC. 2006. Severe communityacquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg. Infect. Dis. 12:894-899.
5. CDC. 2009. Bacterial coinfections in lung tissue specimens from fatal cases of 2009 pandemic influenza A (H1N1)-United States, May-August 2009. MMWR Morb. Mortal. Wkly. Rep. 58:1071-1074.
6. Randolph AG, Vaughn F, Sullivan R, Rubinson L, Thompson BT, Yoon G, Smoot E, Rice TW, Loftis LL, Helfaer M, Doctor A, Paden M, Flori H, Babbitt C, Graciano AL, Gedeit R, Sanders RC, Giuliano JS, Zimmerman J, Uyeki TM, Pediatric Acute Lung Injury and Sepsis Investigator's Network, the National Heart Lung and Blood Institute Clinical Trials Network ARDS. 2011. Critically ill children during the 2009-2010 influenza pandemic in the United States. Pediatrics 128:e1450-e1458.
7. Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA. 2011. Influenza virus primes mice for pneumonia from Staphylococcus aureus. J. Infect. Dis. 203:880-888.
8. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B. 2010. Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. J. Infect. Dis. 202:1287-1295.
9. Lee MH, Arrecubieta C, Martin FJ, Prince A, Borczuk AC, Lowy FD. 2010. A postinfluenza model of Staphylococcus aureus pneumonia. J. Infect. Dis. 201:508-515.
10. Kallen AJ, Brunkard J, Moore Z, Budge P, Arnold KE, Fosheim G, Finelli L, Beekmann SE, Polgreen PM, Gorwitz R, Hageman J. 2009. Staphylococcus aureus community-Acquired pneumonia during the 2006 to 2007 influenza season. Ann. Emerg. Med. 53:358-365.
11. Kallen AJ, Reed C, Patton M, Arnold KE, Finelli L, Hageman J. 2010. Staphylococcus aureus community-onset pneumonia in patients admitted to children's hospitals during autumn and winter of 2006-2007. Epidemiol. Infect. 138:666-672.
12. Guarner J, Bartlett J, Reagan S, Fischer M, Finn S, O'Briain DS, Black M, Hood J, Zaki SR. 2006. Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug use. Hum. Pathol. 37:1482-1488.
13. Paddock CD, Liu L, Denison AM, Bartlett JH, Holman RC, Deleon- Carnes M, Emery SL, Drew CP, Shieh WJ, Uyeki TM, Zaki SR. 2012. Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J. Infect. Dis. 205:895-905.
14. Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B, Greer P, Jones T, Smith C, Bartlett J, Montague J, White E, Rollin D, Gao R, Seales C, Jost H, Metcalfe M, Goldsmith CS, Humphrey C, Schmitz A, Drew C, Paddock C, Uyeki TM, Zaki SR. 2010.2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 177:166-175.
15. Watzinger F, Suda M, Preuner S, Baumgartinger R, Ebner K, Baskova L, Niesters HG, Lawitschka A, Lion T. 2004. Real-time quantitative PCR assays for detection and monitoring of pathogenic human viruses in immunosuppressed pediatric patients. J. Clin. Microbiol. 42:5189-5198.
16. McDougal LK, Fosheim GE, Nicholson A, Bulens SN, Limbago BM, Shearer JE, Summers AO, Patel JB. 2010. Emergence of resistance among USA300 methicillin-resistant Staphylococcus aureus isolates causing invasive disease in the United States. Antimicrob. Agents Chemother. 54: 3804-3811.
17. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Albrecht V, Limbago B, Talan DA, EMERGEncy Study Group ID NET. 2012. Prevalence of methicillin- resistant Staphylococcus aureus as an etiology of community- acquired pneumonia. Clin. Infect. Dis. 54:1126-1133.
18. Lina G, Piemont Y, Godail-Gamot F, Bes M, Peter MO, Gauduchon V, Vandenesch F, Etienne J. 1999. Involvement of Panton-Valentine leukocidin- producing Staphylococcus aureus in primary skin infections and pneumonia. Clin. Infect. Dis. 29:1128-1132.
19. Li HT, Zhang TT, Huang J, Zhou YQ, Zhu JX, Wu BQ. 2011. Factors associated with the outcome of life-threatening necrotizing pneumonia due to community-Acquired Staphylococcus aureus in adult and adolescent patients. Respiration 81:448-460.
20. Badiou C, Dumitrescu O, George N, Forbes AR, Drougka E, Chan KS, Ramdani-Bouguessa N, Meugnier H, Bes M, Vandenesch F, Etienne J, Hsu LY, Tazir M, Spiliopoulou I, Nimmo GR, Hulten KG, Lina G. 2010. Rapid detection of Staphylococcus aureus Panton-Valentine leukocidin in clinical specimens by enzyme-linked immunosorbent assay and immunochromatographic tests. J. Clin. Microbiol. 48:1384-1390.
21. Brown ML, O'Hara FP, Close NM, Mera RM, Miller LA, Suaya JA, Amrine-Madsen H. 2012. Prevalence and sequence variation of Panton- Valentine leukocidin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the United States. J. Clin. Microbiol. 50: 86-90.
22. Shallcross LJ, Fragaszy E, Johnson AM, Hayward AC. 2013. The role of the Panton-Valentine leucocidin toxin in staphylococcal disease: a systematic review and meta-Analysis. Lancet Infect. Dis. 13:43-54.
23. Shopsin B, Mathema B, Zhao X, Martinez J, Kornblum J, Kreiswirth BN. 2000. Resistance rather than virulence selects for the clonal spread of methicillin-resistant Staphylococcus aureus: implications for MRSA transmission. Microb. Drug Resist. 6:239-244.
24. Mera RM, Suaya JA, Amrine-Madsen H, Hogea CS, Miller LA, Lu EP, Sahm DF, O'Hara P, Acosta CJ. 2011. Increasing role of Staphylococcus aureus and community-Acquired methicillin-resistant Staphylococcus aureus infections in the United States: a 10-year trend of replacement and expansion. Microb. Drug Resist. 17:321-328.
25. Klein E, Smith DL, Laxminarayan R. 2009. Community-Associated methicillin- resistant Staphylococcus aureus in outpatients, United States, 1999-2006. Emerg. Infect. Dis. 15:1925-1930.
26. Gillet Y, Issartel B, Vanhems P, Fournet JC, Lina G, Bes M, Vandenesch F, Piemont Y, Brousse N, Floret D, Etienne J. 2002. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 359:753-759.
27. Ferdinands JM, Denison AM, Dowling NF, Jost HA, Gwinn ML, Liu L, Zaki SR, Shay DK. 2011. A pilot study of host genetic variants associated with influenza-Associated deaths among children and young adults. Emerg. Infect. Dis. 17:2294-2302.
28. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, Chin CR, Feeley EM, Sims JS, Adams DJ, Wise HM, Kane L, Goulding D, Digard P, Anttila V, Baillie JK, Walsh TS, Hume DA, Palotie A, Xue Y, Colonna V, Tyler-Smith C, Dunning J, Gordon SB, Gen Investigators ISIS, Investigators MOSAIC, Smyth RL, Openshaw PJ, Dougan G, Brass AL, Kellam P. 2012. IFITM3 restricts the morbidity and mortality associated with influenza. Nature 484:519-523.
29. Carrillo-Marquez MA, Hulten KG, Hammerman W, Lamberth L, Mason EO, Kaplan SL. 2011. Staphylococcus aureus pneumonia in children in the era of community-Acquired methicillin-resistance at Texas Children's Hospital. Pediatr. Infect. Dis. J. 30:545-550.
30. Stockman LJ, Reed C, Kallen AJ, Finelli L, Anderson LJ. 2010. Respiratory syncytial virus and Staphylococcus aureus coinfection in children hospitalized with pneumonia. Pediatr. Infect. Dis. J. 29:1048-1050.
31. Denison AM, Blau DM, Jost HA, Jones T, Rollin D, Gao R, Liu L, Bhatnagar J, Deleon-Carnes M, Shieh WJ, Paddock CD, Drew C, Adem P, Emery SL, Shu B, Wu KH, Batten B, Greer PW, Smith CS, Bartlett J, Montague JL, Patel M, Xu X, Lindstrom S, Klimov AI, Zaki SR. 2011. Diagnosis of influenza from respiratory autopsy tissues: detection of virus by real-time reverse transcription-PCR in 222 cases. J. Mol. Diagn. 13: 123-128.